Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 93

Related Citations for PubMed (Select 22473587)

1.

Chronic eosinophilic leukemia-not otherwise specified has a poor prognosis with unresponsiveness to conventional treatment and high risk of acute transformation.

Helbig G, Soja A, Bartkowska-Chrobok A, Kyrcz-Krzemień S.

Am J Hematol. 2012 Jun;87(6):643-5. doi: 10.1002/ajh.23193. Epub 2012 Mar 31.

PMID:
22473587
2.

Autologous stem-cell transplantation for poor-risk and relapsed intermediate- and high-grade non-Hodgkin's lymphoma.

Nademanee A, Molina A, Dagis A, Snyder DS, O'Donnell MR, Parker P, Stein A, Smith E, Planas I, Kashyap A, Spielberger R, Fung H, Krishnan A, Bhatia R, Wong KK, Somlo G, Margolin K, Chow W, Sniecinski I, Vora N, Slovak M, Niland JC, Forman SJ.

Clin Lymphoma. 2000 Jun;1(1):46-54.

PMID:
11707813
3.

Autologous transplantation of chemotherapy-purged PBSC collections from high-risk leukemia patients: a pilot study.

Lemoli RM, Visani G, Leopardi G, Motta MR, Rizzi S, Testoni N, Curti A, Tura S.

Bone Marrow Transplant. 1999 Feb;23(3):235-41.

5.

Clinical characteristics of patients with chronic eosinophilic leukaemia (CEL) harbouring FIP1L1-PDGFRA fusion transcript--results of Polish multicentre study.

Helbig G, Moskwa A, Hus M, Piszcz J, Swiderska A, Urbanowicz A, Całbecka M, Gajkowska J, Seferyńska I, Hałasz M, Woszczyk D, Markiewicz M, Krzemień S.

Hematol Oncol. 2010 Jun;28(2):93-7. doi: 10.1002/hon.919.

PMID:
19728396
6.

World Health Organization-defined eosinophilic disorders: 2014 update on diagnosis, risk stratification, and management.

Gotlib J.

Am J Hematol. 2014 Mar;89(3):325-37. doi: 10.1002/ajh.23664. Review.

PMID:
24577808
7.

Salvage by timed sequential chemotherapy in primary resistant acute myeloid leukemia: analysis of prognostic factors.

Revesz D, Chelghoum Y, Le QH, Elhamri M, Michallet M, Thomas X.

Ann Hematol. 2003 Nov;82(11):684-90. Epub 2003 Aug 19.

PMID:
12928754
8.

Prognosis of acute myeloid leukemia in the general population: data from southern Switzerland.

Lerch E, Espeli V, Zucca E, Leoncini L, Scali G, Mora O, Bordoni A, Cavalli F, Ghielmini M.

Tumori. 2009 May-Jun;95(3):303-10.

PMID:
19688968
9.

Autologous stem cell transplantation after complete remission and first consolidation in acute myeloid leukemia patients aged 61-70 years: results of the prospective EORTC-GIMEMA AML-13 study.

Thomas X, Suciu S, Rio B, Leone G, Broccia G, Fillet G, Jehn U, Feremans W, Meloni G, Vignetti M, de Witte T, Amadori S.

Haematologica. 2007 Mar;92(3):389-96.

10.

Chronic myeloid leukemia in blast crisis treated with imatinib 600 mg: outcome of the patients alive after a 6-year follow-up.

Palandri F, Castagnetti F, Testoni N, Luatti S, Marzocchi G, Bassi S, Breccia M, Alimena G, Pungolino E, Rege-Cambrin G, Varaldo R, Miglino M, Specchia G, Zuffa E, Ferrara F, Bocchia M, Saglio G, Pane F, Alberti D, Martinelli G, Baccarani M, Rosti G; GIMEMA Working Party on Chronic Myeloid Leukemia.

Haematologica. 2008 Dec;93(12):1792-6. doi: 10.3324/haematol.13068. Epub 2008 Oct 6.

11.

Intensive sequential chemotherapy with repeated blood stem-cell support for untreated poor-prognosis non-Hodgkin's lymphoma.

Stoppa AM, Bouabdallah R, Chabannon C, Novakovitch G, Vey N, Camerlo J, Blaise D, Xerri L, Resbeut M, Di Stefano D, Bardou VJ, Gastaut JA, Maraninchi D.

J Clin Oncol. 1997 May;15(5):1722-9.

PMID:
9164178
12.

Systemic mastocytosis (SM) associated with chronic eosinophilic leukemia (SM-CEL): detection of FIP1L1/PDGFRalpha, classification by WHO criteria, and response to therapy with imatinib.

Florian S, Esterbauer H, Binder T, Müllauer L, Haas OA, Sperr WR, Sillaber C, Valent P.

Leuk Res. 2006 Sep;30(9):1201-5. Epub 2006 Jan 6.

PMID:
16406018
13.

Bone marrow recurrence after initial intensive treatment for childhood acute lymphoblastic leukemia.

Rivera GK, Zhou Y, Hancock ML, Gajjar A, Rubnitz J, Ribeiro RC, Sandlund JT, Hudson M, Relling M, Evans WE, Pui CH.

Cancer. 2005 Jan 15;103(2):368-76.

14.

[Clinicopathologic studies of 13 cases of chronic eosinophilic leukemia].

Wang W, Chen HS, Liu EB, Yang QY, Fang LH, Sun FJ, Qian LS.

Zhonghua Bing Li Xue Za Zhi. 2008 Apr;37(4):259-63. Chinese.

PMID:
18844036
16.

Comparison of high-dose therapy and autologous stem-cell transplantation with conventional therapy for Hodgkin's disease induction failure: a case-control study. Société Francaise de Greffe de Moelle.

André M, Henry-Amar M, Pico JL, Brice P, Blaise D, Kuentz M, Coiffier B, Colombat P, Cahn JY, Attal M, Fleury J, Milpied N, Nedellec G, Biron P, Tilly H, Jouet JP, Gisselbrecht C.

J Clin Oncol. 1999 Jan;17(1):222-9.

PMID:
10458237
17.

Allogeneic bone marrow transplantation for acute lymphoblastic leukemia during first complete remission.

Blume KG, Forman SJ, Snyder DS, Nademanee AP, O'Donnell MR, Fahey JL, Krance RA, Sniecinski IJ, Stock AD, Findley DO, et al.

Transplantation. 1987 Mar;43(3):389-92.

PMID:
3547796
18.

Acute lymphoblastic leukemia in young adults: two chemotherapeutic protocols for the treatment of 46 patients.

Ho CL, Chen YC, Kao WY, Chao TY.

Zhonghua Yi Xue Za Zhi (Taipei). 2000 Jan;63(1):45-52.

PMID:
10645050
19.

Thiotepa cyclophosphamide followed by granulocyte colony-stimulating factor mobilized allogeneic peripheral blood cells in adults with advanced leukemia.

Bacigalupo A, Van Lint MT, Valbonesi M, Lercari G, Carlier P, Lamparelli T, Gualandi F, Occhini D, Bregante S, Valeriani A, Piaggio G, Pitto A, Benvenuto F, Figari O, De Stefano G, Caimo A, Sessarego M.

Blood. 1996 Jul 1;88(1):353-7.

20.

Allogeneic hematopoietic stem cell transplantation for patients with chronic myeloid leukemia in second chronic phase attained by imatinib after onset of blast crisis.

Wang Y, Wu D, Sun A, Jin Z, Qiu H, Miao M, Tang X, Fu Z.

Int J Hematol. 2008 Mar;87(2):167-71. doi: 10.1007/s12185-008-0032-4. Epub 2008 Feb 22.

PMID:
18288566
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk